Aardvark Therapeutics, Inc. Common Stock (AARD) Ownership

$12.40

$0.47 (3.94%)
Last update: 04:00 PM EST
Day's range
$11.9
Day's range
$12.83

Aardvark Therapeutics, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DECHENG CAPITAL LLC 11/14/2025 3.92 M $52.06 M   0.00% 18.06%
CITADEL ADVISORS LLC 11/14/2025 1.36 M $18.07 M   5.93% 6.27%
LAURION CAPITAL MANAGEMENT LP 11/17/2025 1.05 M $13.95 M   6.13% 4.84%
VANGUARD GROUP INC 11/07/2025 555.72 K $7.39 M   20.55% 2.56%
ADAGE CAPITAL PARTNERS GP, L.L.C. 11/14/2025 350.00 K $4.65 M   100.00% 1.61%
MILLENNIUM MANAGEMENT LLC 11/14/2025 319.62 K $4.25 M   100.00% 1.47%
BLACKROCK, INC. 11/12/2025 309.47 K $4.11 M   50.38% 1.43%
SILVERARC CAPITAL MANAGEMENT, LLC 11/12/2025 306.91 K $4.08 M   7.01% 1.42%
SCHONFELD STRATEGIC ADVISORS LLC 11/14/2025 253.75 K $3.37 M   -9.13% 1.17%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 194.04 K $2.58 M   41.71% 0.89%
CRESSET ASSET MANAGEMENT, LLC 11/12/2025 146.78 K $1.95 M   100.00% 0.68%
CANTOR FITZGERALD, L. P. 12/01/2025 96.68 K $1.28 M   26.08% 0.45%
STATE STREET CORP 11/14/2025 93.01 K $1.24 M   149.26% 0.43%
MORGAN STANLEY 11/14/2025 68.46 K $909.86 K   664.08% 0.32%
TWO SIGMA INVESTMENTS, LP 11/14/2025 63.57 K $844.83 K   100.00% 0.29%
NORTHERN TRUST CORP 11/14/2025 57.20 K $760.15 K   26.86% 0.26%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 56.55 K $751.50 K   59.31% 0.26%
UBS GROUP AG 11/13/2025 54.73 K $727.34 K   5.40% 0.25%
BARCLAYS PLC 11/12/2025 39.93 K $530.62 K   -21.03% 0.18%
TWO SIGMA ADVISERS, LP 11/14/2025 25.70 K $341.55 K   100.00% 0.12%
BANK OF AMERICA CORP /DE/ 11/14/2025 23.93 K $318.03 K   199.54% 0.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 22.00 K $292.38 K   100.00% 0.10%
JANE STREET GROUP, LLC 11/14/2025 19.45 K $258.45 K   100.00% 0.09%
GOLDMAN SACHS GROUP INC 11/14/2025 18.93 K $251.54 K   1.79% 0.09%
BANK OF NEW YORK MELLON CORP 11/03/2025 15.52 K $206.30 K   100.00% 0.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 14.24 K $189.25 K   0.00% 0.07%
DEUTSCHE BANK AG\ 11/13/2025 5.73 K $76.09 K   0.00% 0.03%
RHUMBLINE ADVISERS 11/06/2025 5.71 K $75.81 K   3.94% 0.03%
WELLS FARGO & COMPANY/MN 11/13/2025 3.92 K $52.06 K   20.93% 0.02%
NEW YORK STATE COMMON RETIREMENT FUND 11/03/2025 3.82 K $50.81 K   -47.63% 0.02%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2025 2.59 K $34.36 K   -16.37% 0.01%
JPMORGAN CHASE & CO 11/26/2025 2.32 K $30.78 K   -13.49% 0.01%
POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY 11/12/2025 2.12 K $28.18 K   100.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 11/14/2025 1.19 K $15.75 K   -6.55% 0.01%
STRS OHIO 10/30/2025 1.10 K $14.62 K   0.00% 0.01%
STONE HOUSE INVESTMENT MANAGEMENT, LLC 10/27/2025 1.00 K $13.29 K   100.00% 0.00%
LEGAL & GENERAL GROUP PLC 11/13/2025 587 $7.80 K   0.00% 0.00%
AMERITAS INVESTMENT PARTNERS, INC. 11/10/2025 578 $7.68 K   0.00% 0.00%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 469 $6.23 K   100.00% 0.00%
FMR LLC 11/13/2025 363 $4.82 K   100.00% 0.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 11/14/2025 355 $4.72 K   0.28% 0.00%
ROYAL BANK OF CANADA 11/14/2025 305 $4.00 K   13.81% 0.00%
AMALGAMATED BANK 10/29/2025 193 $3.00 K   0.00% 0.00%
STERLING CAPITAL MANAGEMENT LLC 11/12/2025 182 $2.42 K   142.67% 0.00%
CITIGROUP INC 11/10/2025 167 $2.22 K   -91.49% 0.00%
PNC FINANCIAL SERVICES GROUP, INC. 11/07/2025 140 $1.86 K   100.00% 0.00%
EVERSOURCE WEALTH ADVISORS, LLC 11/10/2025 60 $797   100.00% 0.00%
SRS CAPITAL ADVISORS, INC. 11/14/2025 21 $280   100.00% 0.00%
CORMORANT ASSET MANAGEMENT, LP 11/14/2025 0 $0   -100.00% 0.00%

Aardvark Therapeutics, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 49 institutional investors and hedge funds held shares of Aardvark Therapeutics, Inc. Common Stock. The most heavily invested institutionals were:

Decheng Capital LLC: 3.92 M

CITADEL ADVISORS LLC: 1.36 M

Laurion Capital Management LP: 1.05 M

VANGUARD GROUP INC: 555,721

ADAGE CAPITAL PARTNERS GP, L.L.C.: 350,000

MILLENNIUM MANAGEMENT LLC: 319,623

43.64% of Aardvark Therapeutics, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 9.47 M shares in the last 24 months. This purchase volume represents approximately $117.38 M in transactions.